THZ1,
1604810-83-4,
THZ-1,
CDK7 inhibitor,
HY-80013,
CHEMBL3603847,
THZ1 (free base or salt),
GTPL8052,
SCHEMBL14979765,
SCHEMBL18229934,
AOB6457,
EX-A802,
BCP10167,
N-[3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]phenyl]-4-[[(E)-4-(dimethylamino)but-2-enoyl]amino]benzamide,
BDBM50110178,
AKOS026674118,
ZINC149984972,
CS-3167,
SB19466,
NCGC00389590-03,
NCGC00389590-05,
BC600663,
A8882,
J3.509.929H,
A14192,
J-690216,
(E)-N-(3-((5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)-4-(4-(dimethylamino)but-2-enamido)benzamide,
Benzamide, N-[3-[[5-chloro-4-(1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-4-[[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]amino]-,
N-[3-[[4-(1H-Indole-3-yl)-5-chloropyrimidine-2-yl]amino]phenyl]-4-[[4-(dimethylamino)-2-butenoyl]amino]benzamide,
DBeQ,
THZ1 2HCl,
D0LO5B,
;(E)-N-(3-((5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)-4-(4-(dimethylamino)but-2-enamido)benzamide,